FDA.reportPublic FDA data

tavaborole 5 % Topical Solution

RxCUI
1543177
RxNorm name
tavaborole 5 % Topical Solution
Display name
tavaborole 5 % Topical Solution
Full name
tavaborole 5 % Topical Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TAVABOROLETAVABOROLECipla USA Inc.37004451-0345-4e00-96be-f05db600fb9f2025-12-19Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLE TOPICAL SOLUTION, 5%Encube Ethicals, Inc.050f5d10-5591-426e-9020-6516b33633042025-09-15Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEAlembic Pharmaceuticals Limited6da415c6-a9be-42bf-829f-e72ccc5fe3ba2025-02-18Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEViona Pharmaceuticals Incc13610c8-c57a-4519-b37d-eb4fbdcec3982024-12-06Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEZydus Lifesciences Limited15bc62dc-4f5e-4d43-a125-d1f00bee84a52024-12-06Exact identifier
rxcui: 1543177
tavaboroleTAVABOROLEMayne Pharma Commercial LLC7ad9dc39-7501-4db5-a935-d9be8eea30a62024-03-05Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEAlembic Pharmaceuticals Inc.22a6617b-d4b1-405e-901a-0b39a7b2837d2023-12-15Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEChartwell RX, LLC7fe75d38-80a0-444e-84bc-4087b45a791e2023-09-15Adverse reactionsExact identifier
rxcui: 1543177
TavaboroleTAVABOROLEAmneal Pharmaceuticals NY LLCc7f19812-3811-4a3a-9909-43a7a7f134d42019-06-15Adverse reactionsExact identifier
rxcui: 1543177

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
22a6617b-d4b1-405e-901a-0b39a7b2837dtavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]38These highlights do not include all the information needed to use TAVABOROLE TOPICAL SOLUTION safely and effectively. See full prescribing information for TAVABOROLE TOPICAL SOLUTION. TAVABOROLE topical solution Initial U.S. Approval : 201420231215
050f5d10-5591-426e-9020-6516b3363304tavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]37These highlights do not include all the information needed to use tavaborole topical solution safely and effectively. See full prescribing information for tavaborole topical solution. Tavaborole topical solution Initial U.S. Approval: 201420250915
7ad9dc39-7501-4db5-a935-d9be8eea30a6tavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]34These highlights do not include all the information needed to use tavaborole topical solution safely and effectively. See full prescribing information for tavaborole topical solution. Tavaborole topical solution Initial U.S. Approval: 201420240305
37004451-0345-4e00-96be-f05db600fb9ftavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]33These highlights do not include all the information needed to use TAVABOROLE TOPICAL SOLUTION safely and effectively. See full prescribing information for TAVABOROLE TOPICAL SOLUTION. TAVABOROLE topical solution Initial U.S. Approval: 201420251219
15bc62dc-4f5e-4d43-a125-d1f00bee84a5tavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]32Tavaborole Topical Solution20241206
c13610c8-c57a-4519-b37d-eb4fbdcec398tavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]32These highlights do not include all the information needed to use TAVABOROLE TOPICAL SOLUTION safely and effectively. See full prescribing information for TAVABOROLE TOPICAL SOLUTION. TAVABOROLE topical solution Initial U.S. Approval: 201420241206
6da415c6-a9be-42bf-829f-e72ccc5fe3batavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]31These highlights do not include all the information needed to use TAVABOROLE TOPICAL SOLUTION safely and effectively. See full prescribing information for TAVABOROLE TOPICAL SOLUTION. TAVABOROLE topical solution Initial U.S. Approval : 201420250218
7fe75d38-80a0-444e-84bc-4087b45a791etavaborole 5 % Topical Solution [PSN] · tavaborole 43.5 MG/ML Topical Solution [SCD] · tavaborole 5 % Topical Solution [SY]31Tavaborole Topical Solution These highlights do not include all the information needed to use TAVABOROLE TOPICAL SOLUTION safely and effectively. See full prescribing information for TAVABOROLE TOPICAL SOLUTION. TAVABOROLE topical solution Initial U.S. Approval: 201420230915